
In the News
October 22, 2019
Chimeron Bio Announces Appointment of Dr. Robert (Bob) Willette to its Scientific Advisory Board
Chimeron Bio has announced the appointment of Dr. Robert (Bob) Willette to its Scientific Advisory Board.
Chimeron Bio’s unique ChaESAR platform leverages chimera encased self-amplifying RNA (saRNA) to achieve superior expression and broader dynamic range compared to other leading messenger RNA (mRNA) technologies.
We are developing a compelling portfolio of innovative and personalized saRNA-based medicines for people with serious diseases including cancer, infectious diseases, and rare genetic disorders, using our technology to achieve superior patient response at a lower dose.
October 22, 2019
Chimeron Bio has announced the appointment of Dr. Robert (Bob) Willette to its Scientific Advisory Board.
October 22, 2019
RNA, once viewed as passive carriers of genetic information, is arguably the most versatile and potent regulator of biological processes and diseases.
We’re looking for talented individuals to join our team.